These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 23402554)
1. Potential bias in medication adherence studies of prevalent users. Maciejewski ML; Bryson CL; Wang V; Perkins M; Liu CF Health Serv Res; 2013 Aug; 48(4):1468-86. PubMed ID: 23402554 [TBL] [Abstract][Full Text] [Related]
2. Does medication adherence following a copayment increase differ by disease burden? Wang V; Liu CF; Bryson CL; Sharp ND; Maciejewski ML Health Serv Res; 2011 Dec; 46(6pt1):1963-85. PubMed ID: 21689097 [TBL] [Abstract][Full Text] [Related]
3. The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change. Sinnott SJ; Whelton H; Franklin JM; Polinski JM Health Policy; 2017 Jan; 121(1):27-34. PubMed ID: 27916432 [TBL] [Abstract][Full Text] [Related]
4. Effect of copayment policies on initial medication non-adherence according to income: a population-based study. Aznar-Lou I; Pottegård A; Fernández A; Peñarrubia-María MT; Serrano-Blanco A; Sabés-Figuera R; Gil-Girbau M; Fajó-Pascual M; Moreno-Peral P; Rubio-Valera M BMJ Qual Saf; 2018 Nov; 27(11):878-891. PubMed ID: 29545326 [TBL] [Abstract][Full Text] [Related]
5. Effect of a medication copayment increase in veterans with schizophrenia. Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234 [TBL] [Abstract][Full Text] [Related]
6. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350 [TBL] [Abstract][Full Text] [Related]
7. Does the association between prescription copayment increases and medication adherence differ by race? Wong ES; Maciejewski ML; Liu CF J Health Care Poor Underserved; 2013 Aug; 24(3):1317-30. PubMed ID: 23974401 [TBL] [Abstract][Full Text] [Related]
8. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Doshi JA; Li P; Desai S; Marcus SC J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299 [TBL] [Abstract][Full Text] [Related]
9. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Doshi JA; Zhu J; Lee BY; Kimmel SE; Volpp KG Circulation; 2009 Jan; 119(3):390-7. PubMed ID: 19139387 [TBL] [Abstract][Full Text] [Related]
10. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study. Rome BN; Gagne JJ; Avorn J; Kesselheim AS Am Heart J; 2021 Mar; 233():109-121. PubMed ID: 33358690 [TBL] [Abstract][Full Text] [Related]
12. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288 [TBL] [Abstract][Full Text] [Related]
13. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Karter AJ; Parker MM; Moffet HH; Ahmed AT; Schmittdiel JA; Selby JV Health Serv Res; 2009 Oct; 44(5 Pt 1):1640-61. PubMed ID: 19500161 [TBL] [Abstract][Full Text] [Related]
14. Effect of copayments on drug use in the presence of annual payment limits. Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233 [TBL] [Abstract][Full Text] [Related]
15. Tiered Pharmacy Copayments for Medications. Final rule. Department of Veterans Affairs Fed Regist; 2016 Dec; 81(238):89383-91. PubMed ID: 28000499 [TBL] [Abstract][Full Text] [Related]
16. Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population. Kazerooni R; Vu K; Takizawa A; Broadhead C; Morreale AP Womens Health Issues; 2014; 24(2):e237-41. PubMed ID: 24533983 [TBL] [Abstract][Full Text] [Related]
17. The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis. Sinnott SJ; Buckley C; O'Riordan D; Bradley C; Whelton H PLoS One; 2013; 8(5):e64914. PubMed ID: 23724105 [TBL] [Abstract][Full Text] [Related]
18. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment. Domino ME; Martin BC; Wiley-Exley E; Richards S; Henson A; Carey TS; Sleath B Health Serv Res; 2011 Jun; 46(3):900-19. PubMed ID: 21306363 [TBL] [Abstract][Full Text] [Related]
19. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics. Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515 [TBL] [Abstract][Full Text] [Related]
20. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]